Discordant HER2 Status Between Primary Breast Carcinoma and Recurrent/Metastatic Tumors Using Fluorescence In Situ Hybridization on Cytological Samples-Reference-Cited by-同舟云学术

Discordant HER2 Status Between Primary Breast Carcinoma and Recurrent/Metastatic Tumors Using Fluorescence In Situ Hybridization on Cytological Samples

Published:2012-12-07 Issue:1 Volume:43 Page:55-62
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:Japanese Journal of Clinical Oncology

Author:

Arihiro K.,Oda M.,Ogawa K.,Tominaga K.,Kaneko Y.,Shimizu T.,Matsumoto S.,Oda M.,Kurita Y.,Taira Y.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/43/1/55/5108321/hys187.pdf

Reference45 articles.

1. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

2. Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

3. HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discrepancies in Hormone Receptor and HER2 Expression between Malignant Serous Effusions and Paired Tissues from Primary or Recurrent Breast Cancers;Pathobiology;2023-10-10

2. Current applications of molecular testing on body cavity fluids;Diagnostic Cytopathology;2020-03-30

3. Fibroblast growth factor receptor facilitates recurrence of minimal residual disease following trastuzumab emtansine therapy;2019-08-09

4. Breast Carcinoma;Serous Effusions;2018

5. Molecular Cytology of Serous Effusions;Molecular Applications in Cytology;2018